Goyal, A., Alexander, J. H., Hafley, G. E., Graham, S. H., Mehta, R. H., Mack, M. J., … Peterson, E. D. (2006). Greater use of secondary prevention medications following coronary artery bypass graft surgery is associated with improved two-year outcomes. CIRCULATION, 114(18), 796–796.

Goyal, Abhinav, John H. Alexander, Gail E. Hafley, Stacy H. Graham, Rajendra H. Mehta, Michael J. Mack, Randall K. Wolf, et al. “Greater use of secondary prevention medications following coronary artery bypass graft surgery is associated with improved two-year outcomes.” CIRCULATION 114, no. 18 (October 31, 2006): 796–796.

Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, et al. Greater use of secondary prevention medications following coronary artery bypass graft surgery is associated with improved two-year outcomes. CIRCULATION. 2006 Oct 31;114(18):796–796.

Goyal, Abhinav, et al. “Greater use of secondary prevention medications following coronary artery bypass graft surgery is associated with improved two-year outcomes.” CIRCULATION, vol. 114, no. 18, LIPPINCOTT WILLIAMS & WILKINS, Oct. 2006, pp. 796–796.

Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB, Peterson ED. Greater use of secondary prevention medications following coronary artery bypass graft surgery is associated with improved two-year outcomes. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2006 Oct 31;114(18):796–796.